Intravitreal injection. Monitoring to avoid postoperative complications

作者: C.H. Meyer , F. Ziemssen , H. Heimann

DOI: 10.1007/S00347-008-1701-7

关键词:

摘要: Intravitreal injection is generally regarded as safe. Many of the potential complications caused by this procedure are extremely rare and can be avoided careful inspection beforehand proper performance injection. In cases, however, administered drugs may cause various pharmacological side effects. This article summarizes safety profiles Macugen Lucentis from drug approval studies describes initial findings on possible or observed effects after intravitreal administration Avastin. addition, important points to observe in order avoid intra- postoperative provided.

参考文章(70)
M C Dwinger, I Pieper-Bodeewes, N Eter, F G Holz, Variations in intraocular pressure (IOP) and necessity for paracentesis following intravitreal triamcinolone injection Klinische Monatsblatter Fur Augenheilkunde. ,vol. 222, pp. 638- 642 ,(2005) , 10.1055/S-2005-858459
Jacques Gaudreault, David Fei, Jeriza Rusit, Pamela Suboc, Vanessa Shiu, Preclinical pharmacokinetics of Ranibizumab (rhuFabV2) after a single intravitreal administration. Investigative Ophthalmology & Visual Science. ,vol. 46, pp. 726- 733 ,(2005) , 10.1167/IOVS.04-0601
Steve Charles, Philip J. Rosenfeld, Steven Gayer, Medical consequences of stopping anticoagulant therapy before intraocular surgery or intravitreal injections. Retina-the Journal of Retinal and Vitreous Diseases. ,vol. 27, pp. 813- 815 ,(2007) , 10.1097/IAE.0B013E318154B9F2
Mark C. Gillies, What We Don't Know About Avastin Might Hurt Us Archives of Ophthalmology. ,vol. 124, pp. 1478- 1479 ,(2006) , 10.1001/ARCHOPHT.124.10.1478
CHRISTOPHER KISS, STEPHAN MICHELS, FRANZ PRAGER, GüNTHER WEIGERT, WOLFGANG GEITZENAUER, URSULA SCHMIDT-ERFURTH, Evaluation of anterior chamber inflammatory activity in eyes treated with intravitreal bevacizumab. Retina-the Journal of Retinal and Vitreous Diseases. ,vol. 26, pp. 877- 881 ,(2006) , 10.1097/01.IAE.0000237080.10627.B7
Joyce Mordenti, R Andrew Cuthbertson, Napoleone Ferrara, Karen Thomsen, Lea Berleau, Vojtech Licko, Philip C Allen, Celia R Valverde, Y Gloria Meng, David TW Fei, Kathleen M Fourre, Anne M Ryan, None, Comparisons of the intraocular tissue distribution, pharmacokinetics, and safety of 125I-labeled full-length and Fab antibodies in rhesus monkeys following intravitreal administration. Toxicologic Pathology. ,vol. 27, pp. 536- 544 ,(1999) , 10.1177/019262339902700507
Matthew S. Benz, Thomas A. Albini, Eric R. Holz, Rohit R. Lakhanpal, Andrew C. Westfall, Mohan N. Iyer, Petros E. Carvounis, SHORT-TERM COURSE OF INTRAOCULAR PRESSURE AFTER INTRAVITREAL INJECTION OF TRIAMCINOLONE ACETONIDE Ophthalmology. ,vol. 113, pp. 1174- 1178 ,(2006) , 10.1016/J.OPHTHA.2005.10.061
Robert L. Avery, Joel Pearlman, Dante J. Pieramici, Melvin D. Rabena, Alessandro A. Castellarin, Ma’an A. Nasir, Matthew J. Giust, Robert Wendel, Arun Patel, Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy. Ophthalmology. ,vol. 113, pp. 1695- 1705 ,(2006) , 10.1016/J.OPHTHA.2006.05.064
David S Boyer, Andrew N Antoszyk, Carl C Awh, Robert B Bhisitkul, Howard Shapiro, Nisha R Acharya, MARINA Study Group, Subgroup analysis of the MARINA study of ranibizumab in neovascular age-related macular degeneration. Ophthalmology. ,vol. 114, pp. 246- 252 ,(2007) , 10.1016/J.OPHTHA.2006.10.045